← Cockpit
245_011predictionBiotech/Longevitysynbio

Colossal is spinning out a dozen companies each with massive potential

Predictor: Peter Diamandis · ep#245 "AI + Synthetic Biology: The Most Transformative Technology in Human History | Ben Lamm (Colossal)" · source

Prior probability
65.0%
Current probability
54.1%
evolves via intake + LBP
Conviction
4/5
Signal quality
B
Resolution
pending
Window
2026-04-30 – 2028-12-31
Edges in / out
1 / 0
Tickers exposed
24

Prediction text

Colossal is spinning out a dozen companies each with massive potential | so colossal as a parent company is spinning out a dozen companies each of which have massive potential

Verbatim quote

From episode "AI + Synthetic Biology: The Most Transformative Technology in Human History | Ben Lamm (Colossal)"
so colossal as a parent company is spinning out a dozen companies each of which have massive potential

Predictor: Peter Diamandis

κ + Brier as of 2026-05-22
κ (discount)
0.875
Brier
0.0367
excellent
Hits / Misses
10 / 0
of 15 resolved
Hit rate
66.7%
Calibration plot (stated vs observed)

Evidence about this node from Peter Diamandis is multiplied by κ in /api/intake. Lower κ = less weight; floors at 0.10 (effectively silenced) and caps at 1.00 (full weight).

Reference class

Not linked

This node isn't linked to a reference class. The Bayesian update applies without outside-view blending.

Probability over time

7 prob_history rows
0%25%50%75%100%prior 65%2026-04-302026-05-032026-05-24
intake v2milestone miss sweeplbp propagationreference class assignedlegacy v1prior_prob (analyst seed)current = 54.1%

Milestone chain

Pre-event signals (upstream prereqs + window checkpoints) → resolution event → downstream cascades. Status/dates update from linked nodes; re-derive nightly via scripts/ops/derive_milestones.py.
Leading chain: 4 fired ✓ · 9 pending
  1. 2024-12-31hitColossal spins out Breaking (plastic degradation) and Form Bio (computational biology)
    How: Colossal has spun out >=2 standalone companies that have raised independent seed/Series A funding
    Source: https://en.wikipedia.org/wiki/Colossal_Biosciencesconf 99%
    Notes: HIT — Breaking ($10.5M seed for plastic degradation) + Form Bio ($30M for compbio platform) spun out and funded independently.
  2. 2025-01-15hitColossal raises $200M Series C at $10.2B 'decacorn' valuation
    How: Colossal Biosciences closes >=$150M funding round at >=$8B post-money valuation
    Source: https://techcrunch.com/2025/01/15/colossal-biosciences-raises-200m-at-10-2b-valuation-to-bring-back-woolly-mammoths/conf 99%
    Notes: HIT — $200M Series C from TWG Global at $10.2B valuation; ~7x jump from $1.5B prior round.
  3. 2025-01-15hitColossal officially announces plan for 3 additional spinouts (incl. artificial womb tech)
    How: Colossal CEO/founders publicly disclose plan to spin out >=3 additional businesses including artificial womb technology venture
    Source: https://techcrunch.com/2025/01/15/colossal-biosciences-raises-200m-at-10-2b-valuation-to-bring-back-woolly-mammoths/conf 95%
  4. 2026-03-31hitAstromech (Colossal spinout) emerges from stealth at $2B valuation
    How: Astromech publicly emerges from stealth — $10.5M raise, $2B valuation — as Colossal spinout
    Source: https://www.dmagazine.com/business-economy/2026/03/ben-lamm-astromech-colossal/conf 95%
    Notes: HIT — Astromech is the latest of Colossal's announced spinouts (Form Bio, Breaking, Astromech)
  5. 2026-10-20pendingQ1 window check-in (25%)
  6. 2026-06-01 → 2027-12-31pendingColossal spinout count reaches 6+ companies
    How: Colossal has 6+ active spinout companies with independent corporate structure
    Source: https://en.wikipedia.org/wiki/Colossal_Biosciencesconf 55%
    Notes: Diamandis claim is 'a dozen' — 6+ midpoint check. 2 confirmed + 3 announced = 5 baseline.
  7. 2027-04-12pendingQ2 window check-in (50%)
  8. 2026-09-01 → 2027-12-31pendingColossal announces 4th-6th spinout under 'dozen companies' plan
    How: Colossal Biosciences publicly announces ≥3 additional spinouts (beyond Form Bio, Breaking, Astromech)
    Source: https://www.pharmavoice.com/news/dire-wolves-colossal-ben-lamm-pharma-drug-form-bio/802526/conf 70%
  9. 2026-09-01 → 2027-12-31pendingColossal raises follow-on at ≥$15B valuation
    How: Colossal Biosciences closes funding round at ≥$15B post-money (vs $10.2B in Jan 2026)
    Source: https://en.wikipedia.org/wiki/Colossal_Biosciencesconf 60%
  10. 2026-09-01 → 2028-03-31pendingForm Bio reaches $100M ARR or $1B valuation milestone
    How: Form Bio publicly reports ≥$100M ARR or raises round at ≥$1B valuation
    Source: https://venturebeat.com/ai/colossal-biosciences-spins-off-form-bio-software-for-computational-life-sciences-breakthroughsconf 55%
  11. 2026-09-01 → 2028-06-30pendingBreaking (plastic-degradation spinout) commercial pilot launched
    How: Breaking announces commercial pilot of X-32 microbe with municipal/industrial customer
    Source: https://www.pharmavoice.com/news/dire-wolves-colossal-ben-lamm-pharma-drug-form-bio/802526/conf 55%
  12. 2027-10-02pendingQ3 window check-in (75%)
  13. 2027-01-01 → 2028-12-31pendingFirst Colossal spinout reaches IPO or >=$1B unicorn valuation
    How: One Colossal spinout (Form Bio, Breaking, womb tech, or future) reaches IPO or independent unicorn ($1B+) valuation
    Source: https://pitchbook.com/profiles/company/481220-47conf 40%
    Notes: Cascade — 'massive potential' claim only validated by exit-stage outcomes.
  14. 2028-12-31pendingColossal spinout count reaches 12 companies (Diamandis claim)
    How: Colossal has >=12 spinout companies with independent funding by Diamandis horizon end
    Source: https://www.diamandis.com/blog/abundance-37-no-human-codersconf 30%
    Notes: Cascade — Diamandis (host of source episode) claims 'a dozen.' Actually disclosed plan = 5. Some are 'top secret' per the verbatim. 12 is aggressive.

What if this resolves?

Clamp this prediction TRUE or FALSE and run a counterfactual Gibbs sample. Surfaces the predictions whose marginals shift most under that assumption.
(live posterior: 54%)

Click a button to clamp this prediction and run a Gibbs sample. Returns the predictions whose marginals shift most. ~30s per run; ideal for stress-testing "if X resolves, what else moves?"

Evidence chain

Every probability update with full Bayesian provenance — chronological, latest first
LBP2026-05-24T02:00:02Z54.1%+1.7pp
Network propagation: 52.4% → 54.1%
4-iter LBP, residual 0.01000 · damping 0.5, w_intrinsic 0.5 · method lbp_v3 · run 806b02f8
LBP2026-05-17T02:00:01Z52.4%+3.4pp
Network propagation: 48.9% → 52.4%
5-iter LBP, residual 0.00689 · damping 0.5, w_intrinsic 0.5 · method lbp_v3 · run e607fa96
LBP2026-05-10T02:00:02Z48.9%+6.8pp
Network propagation: 42.1% → 48.9%
6-iter LBP, residual 0.00584 · damping 0.5, w_intrinsic 0.5 · method lbp_v3 · run e5c18d29
LBP2026-05-03T02:00:01Z42.1%+12.4pp
Network propagation: 29.7% → 42.1%
6-iter LBP, residual 0.00677 · damping 0.5, w_intrinsic 0.5 · method lbp_v3 · run 1a683ac9
milestone miss2026-05-01T22:09:22Z29.7%-28.8pp
58.5%(inside prior)29.7%(Bayes, κ=0.87)(no blend — node not linked)
2 milestones missed · 30d grace
Show missed milestones
  • LLR -0.693 · moderate · expected 2024-12-31
    Colossal spins out Breaking (plastic degradation) and Form Bio (computational biology)
  • LLR -0.693 · moderate · expected 2025-01-15
    Colossal raises $200M Series C at $10.2B 'decacorn' valuation
LBP2026-04-30T16:39:51Z58.5%-2.3pp
Network propagation: 60.7% → 58.5%
5-iter LBP, residual 0.00825 · damping 0.5, w_intrinsic 0.5 · method lbp_v2 · run 0c8a4ea3
LBP2026-04-30T02:18:57Z60.7%-4.3pp
Network propagation: 65.0% → 60.7%
5-iter LBP, residual 0.00825 · damping 0.5, w_intrinsic 0.5 · method lbp_v1 · run 592311ef

Network propagation neighbors

Top edges sorted by latest LBP cross-impact
All propagation →

Top incoming (parents)

Edges that influence THIS node's belief

KindNodeTheir probP(c|s=T)P(c|s=F)Δ implied
killerTK13
Biotech/Synbio Safety Event
15.0%0.0500.650+0.019

Top outgoing (children)

Predictions THIS node influences

No outgoing edges.

Ticker exposure

24 ticker(s) linked

Beneficiaries (19)

ABCLNTLASDGRPACBRXRXRLAYDNATXGTWSTABSICRSPILMNMDTABTAZNBNTXGEHCGOOGLSMMNY

Adverse (4)

NVOFMSDVAPFE

Prerequisites (1)

Predictions that must hit first
TypePredTitleDomainLag
killerTK13Biotech/Synbio Safety Event

Dependents (0)

Predictions enabled by this
TypePredTitleDomainLag
No dependents

Expected milestones (6)

From Sheet 17 Monitoring Triggers
Expected byDescriptionStatus
2024-12-31Colossal spins out Breaking (plastic degradation) and Form Bio (computational biology)missed
2025-01-15Colossal raises $200M Series C at $10.2B 'decacorn' valuationmissed
2026-06-30Colossal officially announces plan for 3 additional spinouts (incl. artificial womb tech)pending
2027-12-31Colossal spinout count reaches 6+ companiespending
2028-12-31Colossal spinout count reaches 12 companies (Diamandis claim)pending
2028-12-31First Colossal spinout reaches IPO or >=$1B unicorn valuationpending

Raw metadata

From Thesis_Timeline_v1.0_FINAL workbook
{
  "nia": false,
  "qty": "A dozen companies",
  "url": "https://www.youtube.com/watch?v=Goa6c6Qz__I",
  "mode": "PREDICTION",
  "role": "Host",
  "caveats": "Some are top secret",
  "context": "colossal as a parent company is spinning out a dozen companies each of which have massive potential",
  "verbatim": "so colossal as a parent company is spinning out a dozen companies each of which have massive potential",
  "conv_cues": "is spinning out",
  "direction": "HAPPEN",
  "timeframe": "Near future",
  "conv_level": "HIGH",
  "milestones": [
    {
      "kind": "llm_pre_event",
      "label": "Colossal spins out Breaking (plastic degradation) and Form Bio (computational biology)",
      "notes": "HIT — Breaking ($10.5M seed for plastic degradation) + Form Bio ($30M for compbio platform) spun out and funded independently.",
      "source": "https://en.wikipedia.org/wiki/Colossal_Biosciences",
      "status": "hit",
      "weight": 0.4,
      "ordinal": -13,
      "source_id": null,
      "confidence": 0.99,
      "source_url": "https://en.wikipedia.org/wiki/Colossal_Biosciences",
      "expected_date": "2024-12-31",
      "observed_date": "2024-12-31",
      "research_origin": "deep_research",
      "measurement_criterion": "Colossal has spun out >=2 standalone companies that have raised independent seed/Series A funding"
    },
    {
      "kind": "llm_pre_event",
      "label": "Colossal raises $200M Series C at $10.2B 'decacorn' valuation",
      "notes": "HIT — $200M Series C from TWG Global at $10.2B valuation; ~7x jump from $1.5B prior round.",
      "source": "https://techcrunch.com/2025/01/15/colossal-biosciences-raises-200m-at-10-2b-valuation-to-bring-back-woolly-mammoths/",
      "status": "hit",
      "weight": 0.4,
      "ordinal": -12,
      "source_id": null,
      "confidence": 0.99,
      "source_url": "https://techcrunch.com/2025/01/15/colossal-biosciences-raises-200m-at-10-2b-valuation-to-bring-back-woolly-mammoths/",
      "expected_date": "2025-01-15",
      "observed_date": "2025-01-15",
      "research_origin": "deep_research",
      "measurement_criterion": "Colossal Biosciences closes >=$150M funding round at >=$8B post-money valuation"
    },
    {
      "kind": "llm_pre_event",
      "label": "Colossal officially announces plan for 3 additional spinouts (incl. artificial womb tech)",
      "source": "https://techcrunch.com/2025/01/15/colossal-biosciences-raises-200m-at-10-2b-valuation-to-bring-back-woolly-mammoths/",
      "status": "hit",
      "weight": 0.4,
      "ordinal": -11,
      "source_id": null,
      "confidence": 0.95,
      "source_url": "https://techcrunch.com/2025/01/15/colossal-biosciences-raises-200m-at-10-2b-valuation-to-bring-back-woolly-mammoths/",
      "expected_date": "2025-09-30",
      "observed_date": "2025-01-15",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2026-06-30",
        "from": "2025-01-01"
      },
      "measurement_criterion": "Colossal CEO/founders publicly disclose plan to spin out >=3 additional businesses including artificial womb technology venture"
    },
    {
      "kind": "llm_pre_event",
      "label": "Astromech (Colossal spinout) emerges from stealth at $2B valuation",
      "notes": "HIT — Astromech is the latest of Colossal's announced spinouts (Form Bio, Breaking, Astromech)",
      "source": "https://www.dmagazine.com/business-economy/2026/03/ben-lamm-astromech-colossal/",
      "status": "hit",
      "weight": 0.4,
      "ordinal": -10,
      "source_id": null,
      "confidence": 0.95,
      "source_url": "https://www.dmagazine.com/business-economy/2026/03/ben-lamm-astromech-colossal/",
      "expected_date": "2026-03-31",
      "observed_date": "2026-03-31",
      "research_origin": "deep_research",
      "measurement_criterion": "Astromech publicly emerges from stealth — $10.5M raise, $2B valuation — as Colossal spinout"
    },
    {
      "kind": "quartile_checkpoint",
      "label": "Q1 window chec
... (truncated)